Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
View Older Stories View More Recent Stories
-
Second Sight Medical (EYES) Reports Successful Argus II Implants in France
-
Pre-Open Stock Movers 01/12: (FMI) (TKMR) (CPXX) Higher; (ARWR) (SNDK) (TIF) Lower (more...)
-
Second Sight Medical (EYES) Reports Argus II Approval in Canada
-
Second Sight Announces Underwriter Exercises Over-Allotment Option
-
Second Sight Medical (EYES) IPO Opens Sharply Higher
-
Second Sight Medical Products, Inc. (Nasdaq: EYES) to Ring The Nasdaq Stock Market Closing Bell in Celebration of IPO
-
Second Sight Medical Products (EYES) Prices 3.5M Common IPO at $9/Share

